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The adaptive immune response to Francisella tularensis is dependent on the route of inoculation. Intradermal inoculation with
the F. tularensis live vaccine strain (LVS) results in a robust Th1 response in the lungs, whereas intranasal inoculation produces
fewer Th1 cells and instead many Th17 cells. Interestingly, bacterial loads in the lungs are similar early after inoculation by these
two routes. We hypothesize that the adaptive immune response is influenced by local events in the lungs, such as the type of cells
that are first infected with Francisella. Using fluorescence-activated cell sorting, we identified alveolar macrophages as the first
cell type infected in the lungs of mice intranasally inoculated with F. novicida U112, LVS, or F. tularensis Schu S4. Following
bacterial dissemination from the skin to the lung, interstitial macrophages or neutrophils are infected. Overall, we identified the
early interactions between Francisella and the host following two different routes of inoculation.
Immune responses following bacterial infections are influencedby the route of infection (1–3). Cytokines produced by the in-
nate immune response are critical in shaping the adaptive im-
mune response (reviewed in reference 4). For example, if a naive
CD4 T cell encounters antigen in the presence of interleukin 12
(IL-12), it will differentiate into a Th1 effector T cell, but if it
encounters IL-6 and transforming growth factor  (TGF-) dur-
ing antigen presentation, it will differentiate into a Th17 effector T
cell (4). Our previous experiments with mice using intranasal or
intradermal inoculation with Francisella tularensis subsp. holarc-
tica live vaccine strain (LVS) demonstrated striking differences in
the adaptive immune response in the lungs when these two inoc-
ulation routes were compared (2). Upon either intradermal or
intranasal inoculation with LVS, bacteria rapidly disseminate and
are found in the spleen, liver, and lungs 24 h after inoculation (2).
After 3 days, equivalent bacterial burdens are found in the spleen
and lungs of mice inoculated via either route (2). Despite similar
burdens early after inoculation, intradermally inoculated mice
clear the infection more rapidly than intranasally inoculated mice
and have an increased gamma interferon (IFN-) response. Intra-
dermal inoculation leads to significantly more CD4 and CD8 T
cells producing IFN- in both the spleen and lungs on day 7 post-
inoculation than does intranasal inoculation (2). Faster bacterial
clearance in intradermally inoculated mice correlates with the in-
creased IFN--mediated immune response. IFN- is required for
controlling F. tularensis infection, and administration of recom-
binant IFN- decreases bacterial burdens (5–7). Intranasal infec-
tion leads to an expansion in the lungs of Th17 cells, a CD4 T cell
population not found in intradermally inoculated mice (2, 8, 9).
We conclude that T cell effector function is influenced by the
inoculation route. Thus, it is important to understand the initia-
tion of the immune response and identify the earliest cells infected
by Francisella in the lungs.
Francisella tularensis is a facultative intracellular, Gram-nega-
tive coccobacillus. Infection with F. tularensis causes the zoonotic
disease tularemia, which is endemic in regions of the United States
and Europe. Three strains of Francisella are commonly used by
researchers. Francisella tularensis subsp. tularensis Schu S4 is a type
A strain and highly pathogenic in humans and mice. Francisella
tularensis subsp. holarctica live vaccine strain (LVS) is an attenu-
ated, type B strain and does not cause severe disease in humans
(10). Murine infection with LVS closely resembles human infec-
tion (11). The 50% lethal dose (LD50) for intranasal inoculations
is approximately 103 CFU, and that for intradermal inoculation is
approximately 106 (12, 13). F. novicida U112 does not cause dis-
ease in immunocompetent humans but causes severe disease in
mice with a course similar to that in mice inoculated with Schu S4.
Intranasal inoculation with U112 or Schu S4 is typically fatal in
mice before an adaptive immune response can occur, but low-
dose inoculations with LVS in mice allow for the observation of
the adaptive immune response to Francisella.
Due to similar bacterial burdens early after inoculation but
very different adaptive immune responses for these inoculation
routes, we hypothesized that the adaptive immune response to
Francisella was shaped by events early after inoculation, such as
what type of cell was initially infected. We therefore sought to
identify host cells infected with F. tularensis early after intranasal
and intradermal inoculation. We examined three strains of Fran-
cisella to determine whether all strains exhibit similar tropisms or
if different strains target different cell types. Previously, we found
that alveolar macrophages comprised between 50 and 80% of cells
infected with U112 or LVS 24 h after intranasal inoculation (14).
These experiments, however, identified more infected cells than
the initial bacterial inoculum, suggesting that multiple rounds of
infection had occurred. Therefore, we were interested in identify-
ing the infected cells 4 h postinoculation, before reinfection of new
cell types occurred. We found that alveolar macrophages were the
primary cell type infected after intranasal inoculation and that
interstitial macrophages and neutrophils were the first lung cell
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types infected following intradermal inoculation and bacterial
dissemination. Together, our data demonstrate that the cell types
initially infected with Francisella are dependent on the inoculation
route and are common among the different strains of Francisella.
MATERIALS AND METHODS
Bacteria. Francisella novicida U112 was obtained from Colin Manoil
(University of Washington). F. tularensis subsp. holarctica live vaccine
strain (LVS; ATCC 29684) was obtained from the American Type Culture
Collection (Manassas, VA). F. tularensis subsp. tularensis Schu S4 (NR-
643) was obtained from BEI Resources (Manassas, VA). Bacteria were
grown on chocolate agar supplemented with 1% IsoVitaleX (Becton,
Dickinson) at 37°C. Bacterial inoculations were prepared by removing
bacteria from a lawn grown on chocolate agar and resuspended in sterile
phosphate-buffered saline (PBS) at an optical density at 600 nm (OD600)
of 1 (equivalent to 1  107 CFU/l). To achieve the desired inoculation
dose, appropriate dilutions were made using sterile PBS. Viable bacteria in
each preparation were quantified by serial dilution and plating on choc-
olate agar. All experiments using Schu S4 were performed at the Duke
University NIAID-Regional Biocontainment Laboratory (RBL) under
biosafety level 3 (BSL3) containment.
Mice. C57Bl/6J (B6) mice were obtained from The Jackson Laboratory
(Bar Harbor, ME). All mice were housed under specific-pathogen-free
conditions at the University of North Carolina at Chapel Hill, the RBL, or
the University of Arizona in accordance with their respective Institutional
Animal Care and Use committees. Female mice used for experiments were
between 7 and 12 weeks of age.
Inoculation of mice. For intranasal bacterial inoculations, mice were
anesthetized with 575 mg/kg (of body weight) of tribromoethanol (Aver-
tin; Sigma) administered intraperitoneally. Mice were then intranasally
inoculated with 1  104 CFU of U112, LVS, or Schu S4 suspended in 50 l
of PBS. For intradermal inoculations, mice were inoculated with 5  105
CFU of U112 or LVS in 25 l in the tail. The inoculum was divided
between three injection sites along the tail.
Single-cell suspension of mouse lung. Following humane euthanasia,
lungs were aseptically removed after perfusion with PBS and digested into
a single-cell suspension as previously described (15). For intranasally in-
oculated mice, 50 g/ml of gentamicin (Sigma) was added to the digestion
mix to kill extracellular bacteria. Red blood cells were lysed using ammo-
nium chloride-potassium lysis buffer (Gibco) and washed with RMPI
1640 supplemented with 10% fetal calf serum (Atlas), L-glutamine, so-
dium pyruvate, and -mercaptoethanol. The total number of viable cells
was determined using a hemocytometer by trypan blue exclusion.
Bead enrichment of CD45 cells. Lung single-cell suspensions were
stained for 20 min on ice with CD45-allophycocyanin (CD45-APC; clone
30 –F11; Biolegend). After washing the cells to remove unbound antibody,
IMag anti-APC magnetic particles (BD) were used to enrich CD45-APC-
positive cells according to the manufacturer’s instructions. CD45 enrich-
ment was determined by flow cytometry. Enriched eukaryotic cells were
directly plated on chocolate agar containing 10 g/ml of ampicillin
(Sigma), and the CFU were counted 72 h later.
Identification of infected lung populations. Lung cells in a single-cell
suspension after intranasal inoculation with Francisella had Fc receptors
blocked with 2.4G2 to prevent nonspecific staining and were then stained
with F4/80 phycoerythrin (PE; clone BM8; eBioscience), CD11b Pacific
blue (clone M1/70; Biolegend), and CD11c APC (clone N418; eBiosci-
ence). Lung cells from intradermally inoculated mice had Fc receptors
blocked with 2.4G2 and were then stained with F4/80 PE, CD11b Pacific
blue, CD11c APC, and GR-1 Pacific orange (clone RB6-8C5; Invitrogen).
The cells were sorted using a Reflection cell sorter (iCyt/Sony; UNC) or
FACSAria II (Becton Dickinson Immunocytometry Systems [BDIS]; RBL
and University of Arizona) into four populations based on surface marker
expression (Table 1) using the gating scheme shown in Fig. 1. Sorted
populations were plated directly on chocolate agar containing 10 g/ml of
ampicillin without lysis, and bacterial CFU were counted 24 to 72 h later
to enumerate the infected cells.
TABLE 1 Identification of lung cell types infected by Francisella
Cell type Surface markersa
Alveolar macrophages F4/80high, CD11chigh, CD11bmid,
DEC-205mid
Interstitial macrophages F4/80high, CD11cvar, CD11bhigh
Dendritic cells F4/80low, CD11chigh, CD11blow
Neutrophils F4/80low,CD11bhigh, GR-1high
Other F4/80low, CD11clow, CD11bvar
Alveolar macrophages (17) F4/80pos, CD11cneg, CD11bpos,
DEC-205neg
Airway dendritic cells (17) F4/80var, CD11cpos, CD11bvar, GR-1var,
DEC-205pos
Alveolar macrophages (23) F4/80low, CD11chigh, CD11bneg,
DEC-205mid
a mid, medium level; var, variable level; pos, positive expression; neg, not expressed.
FIG 1 Lung gating scheme. Single cells were discriminated from doublets by
plotting side scatter height (SSC-H) versus side scatter area (SSC-A). Cells
were selected by plotting SSC-A versus forward scatter area (FSC-A). F4/80
and F4/80 cells were gated on by plotting FSC-A versus F4/80. From the
F4/80 gate, alveolar macrophages (AMs) were discriminated from interstitial
macrophages (IMs) by plotting CD11c versus CD11b. Of the F4/80 cells,
dendritic cells were identified by plotting CD11c versus CD11b and neutro-
phils were identified by plotting CD11b versus GR-1. For each gate, the per-
centage of the parent gate is indicated in bold (for example, AMs are 4.6% of
the cells within the F4/80 gate).
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Statistical analysis. A Kruskal-Wallis test was used to determine
whether the distribution of infected cells was significantly different and
not due to random sampling. GraphPad Prism (v.5.04) was used for anal-
ysis.
RESULTS
LVS infects myeloid cells after intranasal inoculation. The adap-
tive immune response to LVS is influenced by the route of infec-
tion despite similar bacterial burdens, and therefore antigen load,
early after inoculation (2). We hypothesized that the adaptive im-
mune response in the lungs was shaped by the cell type(s) infected
immediately after intranasal inoculation or after bacterial dissem-
ination to the lungs after intradermal inoculation. We therefore
sought to identify which cell populations were infected following
inoculation. A previous study reported that a variety of lung cell
types are infected with Francisella 24 and 72 h after intranasal
inoculation (16). Although the majority of infected cells 24 h after
intranasal inoculation with green fluorescent protein (GFP)-ex-
pressing Francisella strains were myeloid, alveolar type II epithelial
cells were also identified as an infected cell type by flow cytometry
(16). Therefore, our initial investigation into identifying the first
infected lung cells sought to determine whether cells initially tar-
geted by LVS were of the myeloid or nonmyeloid lineage. We
chose to use 4 h after inoculation so that Francisella had sufficient
time to reach and infect the cells it initially targets but not time for
multiple rounds of reinfection. An intranasal inoculum dose of
1  104 CFU yielded approximately 100 infected cells out of 1 
107 host lung cells at 4 h postinoculation for all strains, giving us
confidence that we were identifying the initially infected cells.
B6 mice were intranasally inoculated with 1  104 CFU of LVS
and euthanized 4 h later. Lung tissue was digested into a single-cell
suspension in the presence of gentamicin to kill extracellular bac-
teria. Cells were then stained with anti-CD45-APC, and anti-APC
magnetic beads were used to positively select for myeloid cells.
Figure 2A shows representative flow cytometry histograms of
CD45 staining within the preenrichment, negative selection
(CD45), and positive selection (CD45) samples. Eukaryotic
cells were directly plated on chocolate agar, and the colonies
within the CD45 and CD45 pools were counted. A total of 99%
of the resulting LVS colonies were on the CD45 plates, indicating
that LVS initially targets myeloid cells for infection (Fig. 2B). Al-
though we did not repeat these experiments using U112 or Schu
S4, we predicted similar results between strains and indeed did
observe that all strains targeted the same cell types after intranasal
inoculation (see below).
Alveolar macrophages are the dominant infected cell type
after intranasal inoculation in all Francisella strains. Of the my-
eloid cells in the lungs, we predicted that alveolar macrophages,
interstitial macrophages, and dendritic cells were the cell types
most likely to be initially infected with Francisella after intranasal
inoculation. To identify infected cells in the lung early after intra-
nasal inoculation, B6 mice were intranasally inoculated with 1 
104 CFU of U112, LVS, or Schu S4 and euthanized 4 h postinoc-
ulation. Lung tissue was digested in the presence of gentamicin to
kill extracellular bacteria. The lung single-cell suspensions were
stained for F4/80, CD11c, and CD11b, and cell populations were
sorted based on expression of these surface markers (Table 1 and
Fig. 1). Sorted eukaryotic cells were plated directly on chocolate

























FIG 2 LVS infects myeloid cells following intranasal inoculation. B6 mice were intranasally inoculated with 1  104 CFU of LVS. Four hours postinfection, mice
were sacrificed and lungs were removed and digested into a single-cell suspension. Cells were stained with CD45-APC, and then CD45 cells were enriched using
magnetic beads. (A) Representative flow cytometry analysis of CD45 enrichment. (B) CD45 and CD45 populations were directly plated on chocolate agar, and
the colonies were counted 72 h later. We counted 123 total CFU among 4 mice. Data are weighted by the total number of CFU and presented as the percentage
of CFU within a population from 4 infected mice in 2 independent experiments.
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counted. Data from multiple mice were combined for each Fran-
cisella strain, and a weighted average was used to identify which
cell type made up the majority of infected cells (Fig. 3). Approxi-
mately 90% of infected cells were alveolar macrophages for each
Francisella strain, indicating that these cells were initially targeted
by Francisella after intranasal inoculation. The remaining 10% of
infected cells consisted of a mixture of interstitial macrophages,
dendritic cells, and others. The results were consistent across in-
dividual mice, although more variability was observed in the mi-
nor infected cell populations (interstitial macrophages, dendritic
cells, and others) (Table 2). In individual mice, alveolar macro-
phages constituted 86 to 96% of infected cells after U112 inocula-
tion, 71 to 93% of infected cells after LVS inoculation, and 93 to
96% of infected cells after Schu S4 inoculation (Table 2). Further-
more, determination of number of LVS CFU per 105 sorted cells
showed that the alveolar macrophage population contained at
least 7-fold more CFU per 105 sorted cells than did interstitial
macrophages, dendritic cells, or others (Fig. 4). Together, these
data indicate that alveolar macrophages are the dominant first
infected cell type immediately after intranasal inoculation with
each of the three distinct strains of Francisella.
Interstitial macrophages and neutrophils are the dominant
infected cell types in the lungs after intradermal inoculation.
We observed very different adaptive immune responses in the
lungs after intranasal versus intradermal inoculation (2) and
therefore hypothesized that different innate immune events oc-
curred early after infection. One possibility was different infected
cell types in the lungs depending on the route of infection, partic-
ularly since one inoculation route introduced bacteria directly
into the lungs, whereas intradermal inoculation required bacteria
to disseminate from the skin to the lungs. We therefore sought to
identify the early infected cell type(s) in the lungs after intrader-
mal inoculation and subsequent bacterial dissemination to the
lungs. Mice were intradermally inoculated with 5  105 CFU of
U112 or LVS. Pilot experiments determined that euthanizing mice
48 h postinoculation allowed enough time for bacteria to dissem-
inate from the skin to the lungs and that 48 h was the earliest time
point that bacteria could be reproducibly found in the lungs. Lung
single-cell suspensions were stained and sorted as previously de-
scribed. In contrast to the case with intranasal inoculation, inter-
stitial macrophages and neutrophils together comprise 90% of
all cells infected with Francisella after intradermal inoculation and
bacterial dissemination to the lungs (Fig. 5 and Table 3). Impor-
tantly, alveolar macrophages were not appreciably infected with
Francisella in the lungs following bacterial dissemination from the











FIG 3 Alveolar macrophages are the primary infected cell type in the lungs
after intranasal inoculation with Francisella. B6 mice were intranasally inocu-
lated with 1  104 CFU of U112, LVS, or Schu S4. Four hours postinoculation,
mice were sacrificed and lungs were removed and digested into a single-cell
suspension and stained for sorting. Alveolar macrophages, interstitial macro-
phages, dendritic cells, and other cell populations were sorted and directly
plated on chocolate agar. Resulting colonies were counted 24 to 72 h later. Data
are weighted by the total number of CFU and presented as the percentage of
CFU within a population from 2 mice (U112; 139 total CFU), 6 mice (LVS; 132
total CFU), or 3 mice (Schu S4; 398 total CFU) from 1 (U112), 3 (LVS), or 2
(Schu S4) independent experiments. A Kruskal-Wallis test was used to deter-
mine whether the distribution of infected cells was significantly different. Sig-
nificant differences were as follows: for U112, not significant (P 
 0.1767); for
LVS, P  0.01; and for Schu S4, P  0.05.
TABLE 2 Mean percentage of infected cells in the lung 4 h after intranasal inoculation
Bacterial strain
% of infected cells, mean  SD (range)
Alveolar macrophages
Interstitial
macrophages Dendritic cells Other
F. novicida U112 (n 
 2) 90.82  6.65 (86.11–95.52) 4.32  0.16 (4.17–4.48) 3.51  3.47 (0.0–6.94) 1.41  1.40 (0.0–2.78)
F. tularensis LVS (n 
 6) 87.86  7.72 (71.43–92.86) 8.13  10.6 (0.0–28.57) 1.67  4.08 (0.0–10) 3.72  4.81 (0.0–9.52)
F. tularensis Schu S4 (n 
 3) 94.27  1.27 (93.33–95.71) 3.45  2.96 (0.83–6.67) 1.90  2.69 (0.0–4.98) 0.38  0.36 (0.0–0.71)
FIG 4 Alveolar macrophages are infected with LVS at the highest frequency.
B6 mice were intranasally inoculated with 1  104 CFU of LVS. Four hours
postinoculation, mice were sacrificed and lungs were removed and digested
into a single-cell suspension and stained for sorting. Alveolar macrophages,
interstitial macrophages, dendritic cells, and other cell populations were sorted
and directly plated on chocolate agar. The total number of sorted cells for each
population was recorded during the sort. Resulting colonies were counted 72 h
later. Data are represented as the number of CFU per 105 sorted cells for each
population from 6 mice in 3 independent experiments.
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number of CFU per 105 sorted cells for each population, we found
that interstitial macrophages and neutrophils were both infected
at a rate over 30 times greater than alveolar macrophages for both
LVS and U112 inoculation (Fig. 6). We detected less than 500
infected cells in the mice intradermally inoculated with LVS. Al-
though we detected more infected cells (100 to 6,000) in the mice
intradermally inoculated with U112, the percentage of each in-
fected cell population was similar to findings for LVS, even with
variability in the number of infected cells, allowing us to be con-
fident that we were observing early infection events in the lungs
following bacterial dissemination. These results indicate that pul-
monary interstitial macrophages and neutrophils are infected
with Francisella in the lungs after intradermal inoculation. Fur-
thermore, these results indicate that different cell types are in-
fected with Francisella in the lungs depending on the inoculation
route and support our hypothesis that the differences observed in
the adaptive immune response are a result of different infected cell
types.
DISCUSSION
Francisella is capable of infecting a variety of cell types upon inoc-
ulation (14, 16–18). The early interactions between the host and
pathogen set the stage for the adaptive immune response. We and
others have shown that the route of inoculation influences the
type of adaptive immune response that develops (2, 3). We were
particularly interested in the early interactions between Francisella
and the host following intranasal and intradermal inoculations
because of differential adaptive immune responses in the lungs.
Intranasal and intradermal inoculations with LVS lead to similar
bacterial burdens early after inoculation, yet the adaptive immune
responses are very different (2). We hypothesized that the cell type
infected with Francisella immediately after inoculation shaped the
adaptive immune response. We therefore sought to identify the
cells that were infected with Francisella after inoculation that were
likely responsible for shaping subsequent adaptive immunity.
We identified infected cells by sorting individual populations
using fluorescence-activated cell sorting. This technique only
identified host cells infected with live Francisella, since our exper-
imental readout was colonies grown on agar. We had to intrana-
sally inoculate mice with 1  104 CFU to have detectable infected
cells after sorting. This inoculum dose is 20-fold higher than our
typical LVS intranasal inoculation dose. We believe that the higher
dose increased the number of infected cells without altering the
distribution of infected cell types because nearly all of the infected
cells were alveolar macrophages.
All three strains of Francisella predominantly infected alveolar
macrophages following intranasal inoculation. Alveolar macro-
phages are the resident macrophages of the airway and interact
with inhaled antigens. It is therefore not surprising that inhalation
of Francisella leads to infection of alveolar macrophages. Other
pathogens, like Mycobacterium tuberculosis, Mycoplasma pulmo-
nis, and Legionella pneumophila, target alveolar macrophages
upon infection as well (19–22). Experiments found that LVS in-
fects pulmonary dendritic cells 1 h after intratracheal inoculation
with 5  104 CFU using flow cytometry to detect carboxyfluores-
cein succinimidyl ester (CFSE)-labeled bacteria inside host cells
(17). A potential explanation for the seemingly disparate results
between the two experiments is the use of different surface mark-
ers to define airway dendritic cells and alveolar macrophages. Sur-
face markers used to define lung cellular populations by our group
and others are shown in Table 1. The markers described by Bosio
and Dow (17) for alveolar macrophages best fit with our definition
of interstitial macrophages, and their definition for airway den-
dritic cells best fits with our definition of alveolar macrophages
(Table 1). More recently, Guth et al. reported that alveolar mac-
rophages express middle levels of DEC-205 and CD11c, giving this
macrophage cell subset a more dendritic-cell-like surface pheno-
type (23). We also observed mid-level expression of DEC-205 of
alveolar macrophages. Therefore, the cell populations are likely
the same based on surface marker phenotype.
While we did not pursue experiments to determine the under-
lying mechanisms responsible for bacterial dissemination, we
identified interstitial macrophages and neutrophils as the domi-
nant infected cell types in the lungs after intradermal inoculation
and bacterial dissemination. We carefully timed the lung harvest
after intradermal inoculation so that we were identifying infected
cells soon after bacteria disseminated to the lungs. These results
indicate that not only does the route of infection shape the adap-
tive immune response but also two different types of innate cells
are initially infected with Francisella in the lungs, which we predict
helps shape the different downstream adaptive responses. In the











FIG 5 Interstitial macrophages and neutrophils are the primary cell types
infected with U112 or LVS in the lungs after intradermal inoculation. B6 mice
were intradermally inoculated with 5  105 CFU of U112 or LVS in 50 l of
PBS at the base of the tail. Forty-eight hours postinoculation, mice were sac-
rificed and lungs were removed and digested into a single-cell suspension and
stained for sorting. Alveolar macrophages, interstitial macrophages, dendritic
cells, and neutrophil populations were sorted and directly plated on chocolate
agar. Resulting colonies were counted 24 to 72 h later. Data are weighted by the
total number of CFU and presented as the percentage of CFU within a popu-
lation from 4 mice (U112; 9,344 total CFU) or 2 mice (LVS; 537 total CFU)
from 1 experiment per strain. A Kruskal-Wallis test was used to determine
whether the distribution of infected cells was significantly different. The dis-
tributions were not significantly different for U112 (P 
 0.1184) or LVS (P 

0.1116).
TABLE 3 Mean percentage of infected cells in the lung 48 h after intradermal inoculation
Bacterial strain
% of infected cells, mean  SD (range)
Alveolar macrophages Interstitial macrophages Dendritic cells Neutrophils
F. novicida U112 (n 
 4) 1.21  1.84 (0.0–3.89) 62.89  26.82 (38.46–100) 0.036  0.044 (0.0–0.089) 35.86  26.75 (0.0–61.54)
F. tularensis LVS (n 
 2) 1.26  1.47 (0.22–2.30) 32.91  11.97 (24.44–41.38) 4.13  5.53 (0.22–8.05) 61.69  18.98 (48.28–75.11)
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ent inoculation routes may simply be spatial. Alveolar macro-
phages are located primarily in the alveoli. This spatial location
would put them in direct contact with Francisella after an intrana-
sal inoculation but out of the way during bacterial dissemination
from the skin.
Because alveolar macrophages were infected following intra-
nasal inoculation with LVS, we sought to determine whether the
disease course was altered in the absence of alveolar macrophages.
Alveolar macrophages express high levels of CD11c and can there-
fore be depleted in CD11c.DOG mice upon intranasal treatment
with diphtheria toxin (DT). We chose to use CD11c.DOG mice
instead of other depletion strategies so that alveolar macrophages
were specifically depleted while other phagocytic cells remained
untouched. Alveolar macrophages can also be depleted by intra-
nasal administration of liposomal clodronate; however, this treat-
ment is nonspecific and depletes 90% of lung and airway anti-
gen-presenting cells (17). Although we successfully depleted
alveolar macrophages from the lungs of CD11c.DOG mice with
intranasal inoculation of diphtheria toxin, this treatment caused
changes to the cytokine and chemokine milieu prior to infection
with LVS (unpublished data). Diphtheria toxin also changed the
proportion and absolute number of lung cellular populations (un-
published data). Although we observed an increase in LVS lung
bacterial burdens when CD11c.DOG mice were depleted of alve-
olar macrophages prior to LVS inoculation, the changes in the
lungs’ cytokine and chemokine milieu as well as cellular distribu-
tion made it impossible to ascribe increased bacterial burdens
simply to the lack of alveolar macrophages.
Alveolar macrophages have been shown in other models to be
both protective and detrimental during infection (17, 19, 24–26).
CBA/J mice succumb rapidly (day 3) to Klebsiella pneumoniae in
the absence of alveolar macrophages and have significantly higher
bacterial burdens in the plasma and lungs, suggesting that alveolar
macrophages control bacterial replication in the lungs (24, 26). B6
mice, normally resistant to Mycoplasma pulmonis, were more sus-
ceptible to infection in the absence of alveolar macrophages, indi-
cating that alveolar macrophages are important for host defense
during M. pulmonis infection (25). In contrast, during Mycobac-
terium tuberculosis infection, mice lacking alveolar macrophages
were less susceptible to infection and had decreased mycobacterial
burdens in the lungs and liver, suggesting that the presence of
alveolar macrophages is detrimental during infection (19). Bosio
and Dow found that depletion of alveolar macrophages with clo-
dronate followed 18 h later by intratracheal inoculation with a
lethal dose of LVS led to decreased bacterial burdens and an in-
crease in mean time to death (17). It is possible that the difference
in bacterial burdens observed in untreated and clodronate-treated
mice was due to the absence of cells to infect, because nearly all
phagocytic cells were reported to be depleted, leaving few cells for
LVS to infect (17). While specific depletion of alveolar macro-
phages might address this possibility, selective depletion of alveo-
lar macrophages without other changes in cellular composition
has not been possible.
Several groups have reported that LVS vaccination prior to
lethal challenge with a highly virulent, type A strain of Francisella
must be administered intranasally and not intradermally in order
to achieve protective immunity (27, 28). The failure of intrader-
mally vaccinated mice to survive a lethal type A challenge suggests
that the T cell response is not successfully primed via this route.
We have demonstrated that the adaptive immune response is dif-
ferent depending on the route of LVS inoculation (2). Herein, we
have shown that different cell types are initially infected with LVS,
again depending on the route of inoculation. Taken together,
these data suggest that alveolar macrophages could play a role in
successful T cell priming (via antigen presentation and/or cyto-
kine milieu), leading to a T cell response that is protective after
secondary challenge with virulent Francisella. Alternatively, when
interstitial macrophages are among the cells initially infected, an
environment is established in which the T cells successfully clear
the primary infection but fail to protect upon secondary challenge.
Overall, we have shown that alveolar macrophages are initially
infected with Francisella in the lungs after intranasal inoculation.
We also determined that interstitial macrophages and neutrophils
are infected with Francisella in the lungs following bacterial dis-
semination from intradermal inoculation in the skin. We had pre-
viously observed a differential adaptive immune response follow-
FIG 6 Interstitial macrophages and neutrophils are infected with U112 and LVS at the highest frequencies. B6 mice were intranasally inoculated with 1  104
CFU of U112 or LVS. Four hours postinoculation, mice were sacrificed and lungs were removed and digested into a single-cell suspension and stained for sorting.
Alveolar macrophages, interstitial macrophages, dendritic cells, and other cell populations were sorted and directly plated on chocolate agar. The total number
of sorted cells for each population was recorded during the sort. Resulting colonies were counted 24 or 72 h later. Data are represented as the number of CFU per
105 sorted cells for each population from 4 (U112) or 2 (LVS) mice in 1 experiment per strain.
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ing intranasal and intradermal inoculation, despite similar
bacterial burdens early after inoculation. We predicted that there
would be differences in the innate immune response in the lungs
that contributed to the development of two distinct T cell re-
sponses, and this was the case; different types of cells were infected
in the lungs following each inoculation route.
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